Orexin A affects ascending contraction depending on downstream cholinergic neurons and descending relaxation through

Yuji Satoh1, Yutaka Okishio, Yasu-Taka Azuma

  • 1Department of Veterinary Pharmacology, Graduate school of Life and Environmental Sciences, Osaka Prefecture University, Gakuen-cho 1-1, Sakai 599-9531, Japan.

Neuropharmacology
|June 10, 2006
PubMed

Insights

Orexin A (OXA) significantly influences mouse jejunal peristalsis by modulating ascending contractions and descending relaxation. Blocking orexin-1 receptors impacts these neural reflexes, highlighting OXA

Area of Science:

  • Gastroenterology
  • Neuroscience
  • Pharmacology

Background:

  • Peristalsis, the wave-like muscle contractions that move food through the digestive tract, is regulated by complex neural pathways.
  • Orexin, a neuropeptide, is known for its role in regulating sleep-wake cycles and appetite, but its involvement in gastrointestinal motility is less understood.

Purpose of the Study:

  • To investigate the role of orexin in the neural control of peristalsis in mouse jejunal segments.
  • To determine the specific neural pathways and receptors involved in orexin-mediated effects on jejunal motility.

Main Methods:

  • Mouse jejunal segments were subjected to localized distension to induce peristaltic reflexes.
  • Pharmacological agents including atropine, tetrodotoxin, hexamethonium, l-nitroarginine, orexin A (OXA), and the orexin-1 receptor antagonist SB-334867-A were used to probe neural pathways.
  • Desensitization and exogenous administration of OXA and nicotine were employed to assess their effects on ascending contraction and descending relaxation.

Main Results:

  • Ascending contraction was mediated by cholinergic and intrinsic enteric neurons, and significantly inhibited by orexin-1 receptor antagonism and hexamethonium.
  • Descending relaxation involved nitrergic pathways and was partially inhibited by orexin-1 receptor antagonism and hexamethonium.
  • Exogenous OXA induced contraction and relaxation, with distinct receptor-mediated pathways compared to nicotine.

Conclusions:

  • Orexin A plays a significant role in both ascending and descending neural reflexes governing peristalsis in the mouse jejunum.
  • Orexin signaling, particularly through the orexin-1 receptor, is a key component of the enteric nervous system's control over gastrointestinal motility.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...